FDA
approval
· 2024-01-22
FDA Approved: FLUVOXAMINE MALEATE — Original Application (Bionpharma Inc.)
Summary
The FDA approved the original ANDA for fluvoxamine maleate from Bionpharma Inc. as a generic version of fluvoxamine, indicated for obsessive-compulsive disorder…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)